Molecular defects in coagulation factor VIII and their impact on factor VIII function

E. L. Saenko*, N. Ananyeva, D. Kouiavskaia, H. Schwinn, D. Josic, M. Shima, C. A.E. Hauser, S. Pipe

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


Molecular defects in Factor VIII (FVIII), such as haemophilia A-related mutations or denaturative conformational changes, may affect the stability of FVIII as well as its interactions with physiological activators, von Willebrand Factor, phospholipid, or conformationally sensitive antibodies. We summarize the contemporary assays which allow identification of impaired functional interactions of FVIII that cause a reduction or loss of its cofactor activity and/or increased immunogenicity. These assays can potentially be used for detection of molecular defects in FVIII and elucidation of the function impaired by these defects.

Original languageEnglish (US)
Pages (from-to)89-96
Number of pages8
JournalVox Sanguinis
Issue number2
StatePublished - Aug 2002
Externally publishedYes


  • Conformational changes
  • Factor VIII
  • Haemophilia A
  • Mutations
  • Phospholipid binding
  • Surface plasmon resonance

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Molecular defects in coagulation factor VIII and their impact on factor VIII function'. Together they form a unique fingerprint.

Cite this